4 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... - 4–6 weeks Alternatives ... #Treatment #management ... #meningitis #cryptococcus ... #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
daily (AI), or Alternative ... Refer to product ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... weekly (BIII) Alternative ... interactions, please refer ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
mg PO daily Alternative ... TB • Please refer ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS